Clinical Trials Directory

Trials / Conditions / Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor

Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor

11 registered clinical trials studyying Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor.

StatusTrialSponsorPhase
Active Not RecruitingTherapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors
NCT01946529
St. Jude Children's Research HospitalPhase 2
WithdrawnWhole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue i
NCT01795430
City of Hope Medical CenterN/A
Completed18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and
NCT01825902
Mayo ClinicEARLY_Phase 1
CompletedVismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced
NCT01154452
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedCollecting and Storing Biological Samples From Patients With Ewing Sarcoma
NCT00899990
Children's Oncology Group—
CompletedBusulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagn
NCT00638898
City of Hope Medical CenterPhase 1
CompletedSorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)
NCT00330421
National Cancer Institute (NCI)Phase 2
CompletedDepsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma
NCT00112463
National Cancer Institute (NCI)Phase 2
CompletedTanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors
NCT00093821
National Cancer Institute (NCI)Phase 1
CompletedDiagnostic Study of Tumor Characteristics in Patients With Ewing's Sarcoma
NCT00048984
Children's Oncology Group—
Completed17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymph
NCT00004241
National Cancer Institute (NCI)Phase 1